Cti Biopharma Corp

VANGUARD GROUP INC

Report date

3/31/2023

Quarter

2023 Q1

Filed

7/14/2023

Shares

5,957,730

Value ($000)

25,022

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	7/14/2023	25,022	0.0%	5,957,730	3/31/2023
2022 Q4	2/10/2023	33,484	0.0%	5,571,411	12/31/2022
2022 Q3	11/14/2022	27,854	0.0%	4,786,023	9/30/2022
2022 Q2	8/12/2022	26,128	0.0%	4,376,439	6/30/2022
2022 Q1	5/13/2022	16,810	0.0%	3,599,415	3/31/2022
2021 Q4	2/14/2022	8,359	0.0%	3,370,815	12/31/2021
2021 Q3	11/12/2021	10,844	0.0%	3,676,004	9/30/2021
2021 Q2	8/13/2021	9,165	0.0%	3,666,204	6/30/2021
2021 Q1	5/14/2021	8,862	0.0%	3,045,312	3/31/2021
2020 Q4	2/12/2021	9,538	0.0%	2,962,312	12/31/2020
2020 Q3	11/16/2020	6,098	0.0%	2,836,130	9/30/2020
2020 Q2	8/14/2020	2,492	0.0%	2,149,048	6/30/2020
2020 Q1	5/15/2020	1,977	0.0%	2,149,048	3/31/2020
2019 Q4	2/14/2020	2,395	0.0%	1,515,674	12/31/2019